Glendale Adventist Medical Center - Adventist Health
Find a Doctor

News at GAMC

Print this page

News from 2009

GAMC To Host FAST-MAG Luncheon
GLENDALE, CA – October 15, 2009 – Glendale Adventist Medical Center will host a
free stroke informational luncheon featuring information on FAST-MAG (Field
Administration of Stroke Therapy – Magnesium Clinical Trial). The luncheon is free, open to the public and will be held on Monday November 9, from Noon to 1:30 p.m. in the Main Auditorium at Glendale Adventist, 1509 Wilson Terrace, Glendale. Event RSVPs are being taken at: (818) 409-8100.
The Field Administration of Stroke Therapy – Magnesium Phase 3 Clinical Trial is an
National Institute of Health and National Institute Neurological Disorders and Stroke
sponsored study whose goal is to evaluate the effectiveness and safety of field-initiated magnesium sulfate in improving the long-term functional outcome of patients with acute stroke.
At this luncheon, Dr. Lance Lee, medical director of the Advanced Primary Stroke Center at Glendale Adventist will discuss the benefits of having an advanced primary stroke center in Glendale. Additionally, a presentation of the FAST-MAG trial as well as review of the effectiveness of magnesium sulfate when given to stroke victims by first responders will be presented by Dr. Jeffrey Saver, UCLA Stroke Program director and Dr. Sidney Starkman, UCLA Emergency Neurology Program director.
According to the American Stroke Association, each year approximately 795,000
Americans suffer a new or recurrent stroke. That means, every 40 seconds, someone in the United States is suffering from a stroke. Stroke kills more than 143,000 people year. This deadly condition accounts for 1 out of every 17 deaths in the United States. Glendale Adventist Medical Center is one of a few certified Advanced Primary Stroke Center’s in Los Angeles County. This certification means that the hospital’s stroke program follows national guidelines that can significantly improve outcomes for stroke patients.
For information about stroke visit, or call (818) 409-8100. For information about the FAST-MAG trial, call (310) 794-6160 or